Novaccess Global Inc XSNX
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.05
- Bid/Ask
- $0.00 / $0.01
- Shares Outstanding
- 61.65M
- Market Cap
- $6,165.24
- Volume/Avg
- 212 / 5,213
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1
- Website
- https://www.novaccessglobal.com
Valuation
|
Metric
|
XSNX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
XSNX
Financial Strength
|
Metric
|
XSNX
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.01 |
Interest Coverage | −3.18 |
Quick Ratio
XSNX
Profitability
|
Metric
|
XSNX
|
|---|---|
Return on Assets (Normalized) | −1,515.43% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
XSNX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|#C%?VZ | LOCK|?bbD# | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|s!<>Z#l | LOCK|bv<yJ | $83B | |||
| Moderna Inc
MRNA
| LOCK|!@G$fq^ | LOCK|># | $80B | |||
| argenx SE ADR
ARGX
| LOCK|>Q%^@%q | LOCK|sPC | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|$L>NhF | LOCK|sw | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|<&C#L? | LOCK|Flrf | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|#M!fFV$ | LOCK|lp?T | $28B | |||
| Incyte Corp
INCY
| LOCK|X?#N!# | LOCK|%%d | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|GZgJ@Qt | LOCK|f^@ | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|@#$hN!B | LOCK|V< | $14B |
United States